KCNH2 Gene Long QT syndrome type 2 Genetic Test sale cost 4400 AED
MYLK2 Gene Cardiomyopathy hypertrophic midventricular digenic Genetic Test sale cost 4400 AED MYLK2 Gene Cardiomyopathy hypertrophic midventricular digenic Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
MT-TE Gene Mitochondrial myopathy infantile transient MT-TE related Genetic Test sale cost 4400 AED MT-TE Gene Mitochondrial myopathy infantile transient MT-TE related Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

KCNH2 Gene Long QT syndrome type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The KCNH2 Gene Long QT Syndrome Type 2 Genetic Test is a specialized diagnostic examination offered at DNA Labs UAE, designed to detect mutations in the KCNH2 gene, which are associated with Long QT Syndrome Type 2 (LQTS2). LQTS2 is a rare inherited condition characterized by abnormal heart rhythms, which can lead to fainting spells, seizures, or sudden death. The condition is named for the elongated QT interval seen on an electrocardiogram (ECG), indicative of delayed heart muscle repolarization.

This genetic test is crucial for individuals with a family history of LQTS or unexplained sudden cardiac death, as it can help in the early identification of the syndrome. Early detection is vital for the management and treatment of LQTS2, which may include lifestyle modifications, medications, or even surgical interventions to prevent potentially life-threatening arrhythmias.

The test is performed by collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific mutations in the KCNH2 gene. The process is comprehensive and designed to ensure accuracy and reliability in the results.

The cost of the KCNH2 Gene Long QT Syndrome Type 2 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of early detection and the potential to save lives through personalized treatment plans cannot be overstated. This test represents a critical step forward in the management of Long QT Syndrome and the broader field of cardiac genetics.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KCNH2 Gene Long QT Syndrome Type 2 Genetic Test

Welcome to DNA Labs UAE, where we offer the KCNH2 Gene Long QT Syndrome Type 2 Genetic Test. This test is designed to diagnose and manage Long QT Syndrome Type 2, a genetic disorder that affects the heart’s rhythm.

Test Components

  • Test Name: KCNH2 Gene Long QT Syndrome Type 2 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cardiovascular Pneumology Disorders
  • Doctor: Cardiologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the KCNH2 Gene Long QT Syndrome Type 2 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the KCNH2 Gene Long QT Syndrome Type 2 NGS Genetic DNA Test gene KCNH2.

Test Details

The KCNH2 gene is responsible for encoding a protein called potassium voltage-gated channel subfamily H member 2, also known as hERG. This protein plays a crucial role in regulating the flow of potassium ions in the heart, which is essential for maintaining a normal heart rhythm.

Long QT Syndrome Type 2 (LQT2) is a genetic disorder characterized by a prolonged QT interval on an electrocardiogram (ECG). This prolonged QT interval increases the risk of developing life-threatening arrhythmias, such as torsades de pointes, which can lead to fainting, seizures, or sudden cardiac arrest.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be associated with a particular condition or disease. In the case of LQT2, NGS genetic testing can be used to identify mutations in the KCNH2 gene that are responsible for the disorder.

By identifying these mutations, healthcare professionals can provide a more accurate diagnosis, assess the risk of arrhythmias, and develop appropriate treatment strategies for individuals with LQT2. This may include lifestyle modifications, medication, or in some cases, implantation of a cardiac defibrillator.

It is important to note that NGS genetic testing for LQT2 should be performed and interpreted by qualified healthcare professionals with expertise in genetic testing and cardiovascular disorders. Genetic counseling may also be recommended to help individuals and their families understand the implications of the test results and make informed decisions about their healthcare.

Test Name KCNH2 Gene Long QT syndrome type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KCNH2 Gene Long QT syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNH2 Gene Long QT syndrome type 2 NGS Genetic DNA Test gene KCNH2
Test Details

The KCNH2 gene is responsible for encoding a protein called potassium voltage-gated channel subfamily H member 2, also known as hERG. This protein plays a crucial role in regulating the flow of potassium ions in the heart, which is essential for maintaining a normal heart rhythm.

Long QT syndrome type 2 (LQT2) is a genetic disorder characterized by a prolonged QT interval on an electrocardiogram (ECG). This prolonged QT interval increases the risk of developing life-threatening arrhythmias, such as torsades de pointes, which can lead to fainting, seizures, or sudden cardiac arrest.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be associated with a particular condition or disease. In the case of LQT2, NGS genetic testing can be used to identify mutations in the KCNH2 gene that are responsible for the disorder.

By identifying these mutations, healthcare professionals can provide a more accurate diagnosis, assess the risk of arrhythmias, and develop appropriate treatment strategies for individuals with LQT2. This may include lifestyle modifications, medication, or in some cases, implantation of a cardiac defibrillator.

It is important to note that NGS genetic testing for LQT2 should be performed and interpreted by qualified healthcare professionals with expertise in genetic testing and cardiovascular disorders. Genetic counseling may also be recommended to help individuals and their families understand the implications of the test results and make informed decisions about their healthcare.

SKU: TEST-3442 Category:

Related products